Cargando…

Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act

Atherosclerotic cardiovascular disease (ASCVD) in its countless clinical presentations is, in industrialized countries, the most frequent cause of death and, in recent years, a leading role in the prevention of ASCVD has been attributed to the treatment of dyslipidaemias. If statins and ezetimibe re...

Descripción completa

Detalles Bibliográficos
Autores principales: Musumeci, Giuseppe, Annibali, Gianmarco, Delnevo, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120980/
https://www.ncbi.nlm.nih.gov/pubmed/37091651
http://dx.doi.org/10.1093/eurheartjsupp/suad086

Ejemplares similares